title: LCZ696 (sacubitril/valsartan): can we predict who will benefit?
authors.affiliation: Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: gdec@partners.org.
authors.forename: G William
authors.initials: GW
authors.lastname: Dec
mesh_terms: D000613:Aminobutyrates / Q000627:therapeutic use*; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D018570:Risk Assessment / Q000379:methods*; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D000613:Aminobutyrates; D013777:Tetrazoles; D004656:Enalapril
keywords: neprilysn inhibition; sacubitril/valsartan